OTC healthcare in New Zealand
1. EXECUTIVE SUMMARY
2. OPERATING ENVIRONMENT
2.1 OTC Registration and Classification
2.2 Vitamins & Dietary Supplements Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 De-listing or De-reimbursement
2.7 Traditional Remedies
2.8 Homeopathy
2.9 Generics
2.10 Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 1999-2004
2.11 Life Expectancy
Table 2 Life Expectancy at Birth 1999-2004
3. OTC HEALTHCARE SALES
3.1 Market Performance
Table 3 Sales of OTC Healthcare by Sector: Value 1999-2004
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 1999-2004
3.2 Switches
Summary 1 OTC Healthcare Switches 2003-2004
Summary 2 OTC Healthcare Reverse Switches (from OTC to Rx) 2003-2004
Summary 3 Proposed OTC Healthcare Switches in 2005
3.3 Competitive Environment
Table 5 OTC Healthcare Company Shares 2001-2004
Table 6 OTC Healthcare Brand Shares 2001-2004
3.4 Leading Company Profiles β Douglas Pharmaceuticals Ltd
Summary 4 Douglas Pharmaceuticals Ltd Operational Indicators 2004
Summary 5 Douglas Pharmaceuticals Ltd: Production Statistics β 2003
3.5 Leading Company Profiles β Healtheries of New Zealand
Summary 6 Healtheries of New Zealand Company Operational Indicators 2003
Summary 7 Healtheries of New Zealand : Production Statistics 2003
3.6 Leading Company Profiles β Pfizer Consumer Healthcare New Zealand
Summary 8 Pfizer Consumer Healthcare New Zealand Operational Indicators 2003
Summary 9 Pfizer Consumer Healthcare New Zealand: Production Statistics
3.7 Retail Distribution
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 1999/2004
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2004
3.8 Retailer Activity and Private Label Trends
Table 9 Penetration of Private Label by Sector 2001-2004
3.9 Forecast Market Performance
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2004-2009
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2004-2009
4. SMOKING CESSATION AIDS SALES
4.1 Number of Smokers
Table 12 Number of Smokers by Gender 1999-2004
4.2 Sector Performance
4.3 Forecast Performance
Table 13 Sales of Smoking Cessation Aids by Subsector: Value 1999-2004
Table 14 Sales of Smoking Cessation Aids by Subsector: % Value Growth 1999-2004
Table 15 Smoking Cessation Aids Company Shares 2001-2004
Table 16 Smoking Cessation Aids Brand Shares 2001-2004
Table 17 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2004-2009
Table 18 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2004-2009
Summary 10 Smoking Cessation Aids: New Product Launches 2003-2004
5. OTHER OTC
6. DEFINITIONS
